Fischer Medical Ventures Ltd — Updates, 11-07-2025: Company Update

Fischer Medical Ventures Ltd’s joint venture partner, Nanyang Biologics (NYB.AI), won the top prize at the SuperAI Genesis competition, recognized for its AI-driven drug discovery platform focused on natural compounds. NYB.AI’s proprietary technology significantly improves accuracy and speed in predicting drug-target interactions, accelerating drug development and reducing costs. The platform’s applications extend beyond pharmaceuticals to nutraceuticals, beauty, and animal health. This win highlights Fischer Medical Ventures’ strategic role in advancing innovative, nature-based healthcare solutions with strong commercial partnerships and global market potential.